ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) Stock Fundamental Analysis

NYSE:AQNB • US0158578080

25.89 USD
-0.01 (-0.04%)
Last: Feb 25, 2026, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 26 industry peers in the Multi-Utilities industry. AQNB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AQNB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • AQNB had positive earnings in the past year.
  • AQNB had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
  • In the past 5 years AQNB always reported a positive cash flow from operatings.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • With a Return On Assets value of -0.27%, AQNB is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
  • AQNB has a Return On Equity of -0.80%. This is amonst the worse of the industry: AQNB underperforms 96.15% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.16%, AQNB is doing worse than 88.46% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AQNB is in line with the industry average of 3.86%.
  • The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • The Operating Margin of AQNB (21.55%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of AQNB has declined.
  • AQNB's Gross Margin of 73.94% is fine compared to the rest of the industry. AQNB outperforms 73.08% of its industry peers.
  • AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
  • Compared to 1 year ago, AQNB has more shares outstanding
  • Compared to 5 years ago, AQNB has more shares outstanding
  • AQNB has a better debt/assets ratio than last year.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AQNB has an Altman-Z score of 1.32. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
  • AQNB's Altman-Z score of 1.32 is amongst the best of the industry. AQNB outperforms 92.31% of its industry peers.
  • A Debt/Equity ratio of 1.33 is on the high side and indicates that AQNB has dependencies on debt financing.
  • AQNB has a better Debt to Equity ratio (1.33) than 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.45
WACC7.06%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • AQNB has a Current Ratio of 1.23. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Current ratio value of 1.23, AQNB belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
  • A Quick Ratio of 1.03 indicates that AQNB should not have too much problems paying its short term obligations.
  • AQNB's Quick ratio of 1.03 is amongst the best of the industry. AQNB outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for AQNB have decreased strongly by -29.79% in the last year.
  • Measured over the past years, AQNB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.38% on average per year.
  • Looking at the last year, AQNB shows a very negative growth in Revenue. The Revenue has decreased by -23.92% in the last year.
  • The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%

3.2 Future

  • Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 4.09% on average per year.
  • Based on estimates for the next years, AQNB will show a small growth in Revenue. The Revenue will grow by 2.30% on average per year.
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • AQNB is valuated quite expensively with a Price/Earnings ratio of 78.45.
  • 96.15% of the companies in the same industry are cheaper than AQNB, based on the Price/Earnings ratio.
  • AQNB is valuated expensively when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 70.64, the valuation of AQNB can be described as expensive.
  • 96.15% of the companies in the same industry are cheaper than AQNB, based on the Price/Forward Earnings ratio.
  • AQNB is valuated expensively when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 78.45
Fwd PE 70.64
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AQNB is valued expensively inside the industry as 96.15% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.83
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.48%
EPS Next 3Y6.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • AQNB has a Yearly Dividend Yield of 4.01%, which is a nice return.
  • AQNB's Dividend Yield is a higher than the industry average which is at 3.87.
  • Compared to an average S&P500 Dividend Yield of 1.80, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.01%

5.2 History

  • The dividend of AQNB has a limited annual growth rate of 0.06%.
  • AQNB has been paying a dividend for over 5 years, so it has already some track record.
  • AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • AQNB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-569.86%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

25.89

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07
Earnings (Next)03-06
Inst Owners74.14%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.89B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts71.67
Price Target20.49 (-20.86%)
Short Float %0%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield 4.01%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)1.39%
PT rev (3m)-1.78%
EPS NQ rev (1m)-6.89%
EPS NQ rev (3m)-15.62%
EPS NY rev (1m)0%
EPS NY rev (3m)3.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.46%
Valuation
Industry RankSector Rank
PE 78.45
Fwd PE 70.64
P/S 8.33
P/FCF N/A
P/OCF 42.71
P/B 4.28
P/tB 6.1
EV/EBITDA 28.83
EPS(TTM)0.33
EY1.27%
EPS(NY)0.37
Fwd EY1.42%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.34%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.32
F-Score4
WACC7.06%
ROIC/WACC0.45
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year48.7%
EBIT Next 3Y21.37%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


How financially healthy is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

The financial health rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 4 / 10.


Can you provide the dividend sustainability for AQNB stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.